We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
Turnover
17.24%
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
-6.3%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$563M
AUM Growth
-$77.2M
(-12%)
Cap. Flow
+$3.41M
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
62.51%
Holding
124
New
20
Increased
17
Reduced
10
Closed
12
Avg Time Held
1.1
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GPGI Inc
GPGI
|
+$11M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$10.8M |
| 3 |
Brunswick
BC
|
+$5.76M |
| 4 |
Televisa
TV
|
+$5.18M |
| 5 |
Duos Technologies
DUOT
|
+$4.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$32.8M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$3.66M |
| 3 |
IHC
Independence Holding Company
IHC
|
+$3.1M |
| 4 |
Enterprise Products Partners
EPD
|
+$2.77M |
| 5 |
TLMD
SOC Telemed, Inc. Class A Common Stock
TLMD
|
+$2.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.74% |
| 2 | Miscellaneous | 15.57% |
| 3 | Industrials | 15.14% |
| 4 | Financials | 14.94% |
| 5 | Materials | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
LGF.B
76
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $247K | 0.04% |
16,413
| – | – |
2019 Q4
9 quarters
|
|
77
Otis Worldwide
OTIS
$26.8B
| $231K | 0.04% |
3,000
| – | – |
2020 Q2
7 quarters
|
|
78
Sprott Physical Gold
PHYS
$14.9B
| $193K | 0.03% |
12,540
| – | – |
2019 Q4
9 quarters
|
|
79
Filana Therapeutics
FLNA
$36.8M
| $186K | 0.03% |
5,000
-7,500
| -60% | -$318K |
2021 Q4
1 quarter
|
|
|
CORS.WS
80
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
| $175K | 0.03% |
416,666
| – | – |
2021 Q3
2 quarters
|
|
|
EQRXW
81
DELISTED
EQRx, Inc. Warrant
EQRXW
| $165K | 0.03% |
200,000
| – | – |
2021 Q2
3 quarters
|
|
82
Liberty Latin America Class C
LILAK
$1.6B
| $158K | 0.03% |
18,174
| – | – |
2020 Q2
7 quarters
|
|
83
DELISTED
CompoSecure Inc Warrant
CMPOW
| $155K | 0.03% |
+100,000
| New | +$140K |
2022 Q1
0 quarters
|
|
|
PACXW
84
DELISTED
Pioneer Merger Corp. Warrant
PACXW
| $143K | 0.03% |
708,333
| – | – |
2021 Q2
3 quarters
|
|
85
DELISTED
OppFi Inc Warrants
OPFI.WS
| $129K | 0.02% |
250,000
| – | – |
2021 Q3
2 quarters
|
|
86
Advanced Micro Devices
AMD
$918B
| $100K | 0.02% |
+913
| New | +$109K |
2022 Q1
0 quarters
|
|
87
Bank of New York Mellon
BNY
$96.4B
| $99K | 0.02% |
2,000
| – | – |
2020 Q1
8 quarters
|
|
88
ExxonMobil
XOM
$718B
| $89K | 0.02% |
1,075
| – | – |
2020 Q2
7 quarters
|
|
89
Cadence Design Systems
CDNS
$89.3B
| $86K | 0.02% |
525
| – | – |
2020 Q2
7 quarters
|
|
90
AbbVie
ABBV
$501B
| $83K | 0.01% |
515
| – | – |
2020 Q2
7 quarters
|
|
|
ISLEW
91
DELISTED
Isleworth Healthcare Acquisition Corporation Warrant
ISLEW
| $83K | 0.01% |
500,000
| – | – |
2021 Q1
4 quarters
|
|
92
Teradyne
TER
$53.7B
| $71K | 0.01% |
600
| – | – |
2020 Q2
7 quarters
|
|
|
FAZEW
93
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
| $68K | 0.01% |
75,000
| – | – |
2021 Q2
3 quarters
|
|
94
Alliance Entertainment Holding Corp Warrants
AENTW
| $64K | 0.01% |
200,000
| – | – |
2021 Q2
3 quarters
|
|
95
Lumentum
LITE
$78.8B
| $64K | 0.01% |
660
| – | – |
2020 Q2
7 quarters
|
|
96
Altria Group
MO
$123B
| $63K | 0.01% |
1,200
| – | – |
2020 Q2
7 quarters
|
|
97
X4 Pharmaceuticals
XFOR
$262M
| $63K | 0.01% |
1,191
| – | – |
2019 Q4
9 quarters
|
|
98
Liberty Latin America Class A
LILA
$1.62B
| $39K | 0.01% |
5,913
| – | – |
2020 Q1
8 quarters
|
|
99
AT&T
T
$161B
| $39K | 0.01% |
2,185
| – | – |
2020 Q2
7 quarters
|
|
|
BRIVW
100
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
| $38K | 0.01% |
75,000
| – | – |
2021 Q3
2 quarters
|
|
Similar funds
NFW
SCM
PHC
EPM
BCM
FAM
WDG
OC
Bleichroeder LP's Q1 2022 Portfolio in Review
As of Q1 2022, Bleichroeder LP held 124 positions worth $563M, down 12% from $641M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Bleichroeder LP's Q1 2022 filing shows 20 new, 17 increased, 10 reduced and 12 closed positions. Its largest new stake was GPGI Inc: 1,776,008 shares worth $11.2M. The largest sale was Royalty Pharma, an estimated $32.8M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Industrials.
- Bleichroeder LP's largest Q1 2022 buy was GPGI Inc: 1,776,008 shares worth $11.2M.
- Bleichroeder LP added most to CTI BioPharma Corp. (DE) Common Stock in Q1 2022, an estimated $10.8M increase.
- Bleichroeder LP's biggest Q1 2022 reduction was Tricida, Inc. Common Stock, cutting an estimated $1.53M.
- Bleichroeder LP fully exited Royalty Pharma in Q1 2022, selling an estimated $32.8M.
- Bleichroeder LP's ten largest holdings make up 63% of its $563M portfolio in Q1 2022.
- Bleichroeder LP opened 20 new positions and closed 12 in Q1 2022.
- Bleichroeder LP's portfolio value fell 12% quarter-over-quarter to $563M.
Based on Bleichroeder LP's 13F filing for Q1 2022, filed 11 May 2022.